Explicit Inclusion Criteria

Explicit inclusion criteria establish precisely defined patient characteristics identifying trial eligible populations. Age ranges, disease severity, and organ function specifications target intended populations. Biomarker requirements ensure patient-population genetic or molecular homogeneity. Prior treatment history exclusions eliminate confounding effects. Comorbidity restrictions focus analysis on disease-specific effects.

Protocol specificity prevents investigator interpretation bias. Screening failure documentation tracks eligibility assessment accuracy. Regulatory guidance recommends explicit criteria over subjective judgements. Patient recruitment balances strict criteria against enrollment feasibility. Post-approval monitoring confirms real-world patient populations match trial eligibility profiles.